Exploring the Genome-wide Association Study of the Population With Clinical Cure Advantage in the Treatment of Chronic Hepatitis B With Long-acting Interferon

NCT06696664 · clinicaltrials.gov ↗

RECRUITING

Status

120

Enrollment

OTHER_GOV

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: PEG-IFN-α

Sponsor

Minghui Li